Georgetown University Medical Center — Washington D.C., District of Columbia

Georgetown University Medical Center is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.

Georgetown University Medical Center has participated in 276 clinical trials with 72 currently active.

Therapeutic areas: Castrate-Resistant Prostate Cancer, Polycythemia Vera, Essential Thrombocythemia.

Sponsors: Hoffmann-La Roche, John Mascarenhas, Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Georgetown University Medical Center?

Georgetown University Medical Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Georgetown University Medical Center conducted?

Georgetown University Medical Center has 276 clinical trials on record, with 72 currently active. Their work covers Castrate-Resistant Prostate Cancer, Polycythemia Vera, Essential Thrombocythemia.

Is Georgetown University Medical Center accredited by Crixeo Health?

Georgetown University Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Georgetown University Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.